Veterinary Medicines

Nobivac KC nasal drops, lyophilisate and solvent for suspension for dogs

Authorised
  • Bordetella bronchiseptica, strain B-C2, Live
  • Canine parainfluenza virus, strain Cornell, Live
Download as PDF

Identifikacija zdravila

Ime zdravila:
Nobivac KC
Nobivac KC nasal drops, lyophilisate and solvent for suspension for dogs
Učinkovina:
Ciljne živalske vrste:
Pot uporabe:
  • Nazalna uporaba

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    9.70
    log10 colony forming unit(s)
    /
    0.40
    millilitre(s)
  • Na voljo samo v English
    5.80
    log10 tissue culture infective dose 50
    /
    0.40
    millilitre(s)
Farmacevtska oblika:
  • Pršilo za nos, liofilizat in vehikel za suspenzijo
Withdrawal period by route of administration:
  • Nasal use
    • Dog
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QI07AF
Pravni status za dobavo / izdajo zdravila:
  • Zdravilo, ki se izdaja na veterinarski recept
Status dovoljenja:
  • Valid
Authorised in:
  • Portugal
Opis ovojnine:

Dodatne informacije

Entitlement type:
Pravna podlaga za izdajo dovoljenja za promet z zdravilom:
Imetnik dovoljenja za promet z zdravilom:
  • MSD Animal Health Lda.
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • INTERVET INTERNATIONAL B.V.
Pristojni organ:
  • Directorate General For Food And Veterinary
Številka dovoljenja :
  • 668/00DGV
Datum spremembe statusa dovoljenja:
Referenčna država članica:
Številka postopka:
  • IT/V/0134/001
Zadevne države članice:

Dokumenti

Combined File of all Documents

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.
English (PDF)
Objavljeno na: 13/02/2024
Prenesi
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."